Atlas Trials

Renibus Therapeutics, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Renibus Therapeutics, Inc.

RecordFirmDate
Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (NCT06021457)Renibus Therapeutics, Inc.2023-10-17
An Evaluation of Patient Reported Outcomes and Clinical Outcomes (NCT06092970)Renibus Therapeutics, Inc.2023-10-16
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery (NCT04564833)Renibus Therapeutics, Inc.2021-08-04
A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) (NCT04364763)Renibus Therapeutics, Inc.2020-08-05
A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease (NCT03893799)Renibus Therapeutics, Inc.2019-08-27
A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease (NCT04072861)Renibus Therapeutics, Inc.2019-03-31
A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease (NCT04072432)Renibus Therapeutics, Inc.2018-10-21
RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD (NCT03630029)Renibus Therapeutics, Inc.2018-09-15

Track Renibus Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.